Literature DB >> 18852650

The utility of extended criteria donor organs in severely ill liver transplant recipients.

Jens Mittler1, Andreas Pascher, Peter Neuhaus, Johann Pratschke.   

Abstract

Organ shortage in liver transplantation has led the transplant community to expand the donor organ pool and reduce waiting list mortality by using so-called marginal donor or extended criteria donor (ECD) livers. The exact impact of these criteria on graft function and recipient survival are still under investigation. Most reports, however, show a clear correlation between organ quality and the posttransplant outcome. The role of ECD liver transplantation for severely ill recipients with high model for end stage liver disease (MELD) scores needs further clarification since transplant surgeons tend to allocate these grafts to more stable patients with lower MELD scores. Especially in the setting of ECD liver transplantation, strategies to improve graft quality and mitigate preservation and reperfusion injury may prove beneficial and play an important role in the future.

Entities:  

Mesh:

Year:  2008        PMID: 18852650     DOI: 10.1097/TP.0b013e318186ad7a

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  7 in total

1.  8-pCPT-cGMP prevents mitochondrial depolarization and improves the outcome of steatotic partial liver transplantation.

Authors:  Qinlong Liu; Hasibur Rehman; Yasodha Krishnasamy; John J Lemasters; Zhi Zhong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2017-06-15

2.  Role of inducible nitric oxide synthase in mitochondrial depolarization and graft injury after transplantation of fatty livers.

Authors:  Qinlong Liu; Hasibur Rehman; Yasodha Krishnasamy; Venkat K Ramshesh; Tom P Theruvath; Kenneth D Chavin; Rick G Schnellmann; John J Lemasters; Zhi Zhong
Journal:  Free Radic Biol Med       Date:  2012-05-15       Impact factor: 7.376

3.  Inhibition of inducible nitric oxide synthase prevents mitochondrial damage and improves survival of steatotic partial liver grafts.

Authors:  Songqing He; Hasibur Rehman; Gary L Wright; Zhi Zhong
Journal:  Transplantation       Date:  2010-02-15       Impact factor: 4.939

4.  The augmenter of liver regeneration protects the kidneys after orthotopic liver transplantation possibly by upregulating HIF-1α and O2-sensitive K+ channels.

Authors:  Yao Chen; Fang Luo; Shiqiao Luo; Zhongjun Wu; Jian Zhou
Journal:  Surg Today       Date:  2011-03-02       Impact factor: 2.549

5.  Safety and feasibility of third-party multipotent adult progenitor cells for immunomodulation therapy after liver transplantation--a phase I study (MISOT-I).

Authors:  Felix C Popp; Barbara Fillenberg; Elke Eggenhofer; Philipp Renner; Johannes Dillmann; Volker Benseler; Andreas A Schnitzbauer; James Hutchinson; Robert Deans; Deborah Ladenheim; Cheryl A Graveen; Florian Zeman; Michael Koller; Martin J Hoogduijn; Edward K Geissler; Hans J Schlitt; Marc H Dahlke
Journal:  J Transl Med       Date:  2011-07-28       Impact factor: 5.531

6.  The impact of major extended donor criteria on graft failure and patient mortality after liver transplantation.

Authors:  Vladimir J Lozanovski; Elias Khajeh; Hamidreza Fonouni; Jan Pfeiffenberger; Rebecca von Haken; Thorsten Brenner; Markus Mieth; Peter Schirmacher; Christoph W Michalski; Karl Heinz Weiss; Markus W Büchler; Arianeb Mehrabi
Journal:  Langenbecks Arch Surg       Date:  2018-08-15       Impact factor: 2.895

7.  [Extended donor criteria defined by the German Medical Association : study on their usefulness as prognostic model for early outcome after liver transplantation].

Authors:  H Schrem; B Reichert; N Frühauf; M Kleine; L Zachau; T Becker; F Lehner; H Bektas; J Klempnauer
Journal:  Chirurg       Date:  2012-11       Impact factor: 0.955

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.